Yes, we got a better deal for RoW compared to US due to the timing of it. The drug is likely to fetch a lower price in the EU though. I would imagine that long term EU should be similar market size to the US. More patients, slightly less cost $$
Ann: Trofinetide marketing application submitted in Europe, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.66 |
Change
-0.040(0.24%) |
Mkt cap ! $2.098B | |||
| Open | High | Low | Value | Volume |
| $16.68 | $16.86 | $16.51 | $2.870M | 172.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 127 | $16.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.66 | 140 | 8 |
View Market Depth
| Last trade - 14.45pm 30/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |